Nadav Kidron, President and CEO at ORAMED PHARMACEUTICALS INC. (ORMP), bought 200,000 shares at $2.01 ($402K) on 2023-03-14, disclosed to the SEC on 2023-03-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 100,000 | $201K | 50.0% |
| 2 | $2.01 | 100,000 | $201K | 50.0% |
| Total | $2.01 avg | 200,000 | $402K | 100% |
| Filing → |
| ORMP | BUY | 2018-07-12 | $722 | — | Filing → |
| ORMP | SELL | 2018-07-12 | $365 | — | Filing → |
| ORMP | BUY | 2016-05-12 | $7K | — | Filing → |